Peapack Gladstone Financial Aktie 836130 / US7046991078
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
|
25.09.2025 16:35:31
|
EQS-News: Robert Melle Joins the Wealth Management Team at Peapack Private
|
EQS-News: Peapack-Gladstone Financial Corporation
/ Key word(s): Financial
BEDMINSTER, NJ - September 25, 2025 (NEWMEDIAWIRE) - Peapack-Gladstone Financial Corporation (NASDAQ Global Select Market: PGC) and Peapack Private Bank & Trust are pleased to announce the appointment of Robert Melle as Senior Managing Director and Senior Financial Advisor with the wealth management division of Peapack Private. Based at the firm’s Park Avenue office in New York City, Robert joins a growing team of advisors focused on expanding the Bank’s wealth management presence in Manhattan. A seasoned sales and service-driven professional with over 25 years of experience, Robert has a strong record of driving business success through strategic financial planning and client advocacy. His expertise spans wealth planning, asset allocation, investment strategy, and financial advisory, complemented by deep capabilities in lead generation, product development, and solution implementation. He is also highly skilled in relationship management, negotiation, risk mitigation, and strategic process alignment. Robert joins Peapack Private from Charles Schwab, where he served as Vice President and Financial Consultant, delivering comprehensive wealth management services and proactive relationship management to ultra-high- and high-net-worth clients. His prior roles include distinguished positions at Chase Investment Services Corporation and Citicorp Investment Services, based in New York. Over the course of his career, Robert has overseen asset management exceeding $1.2 billion, with advisory fee assets totaling more than $220 million. He has consistently ranked in the top 25% of regional financial consultants and earned multiple Northeast Achievement and Key Contributor Stock Awards. Nationally, he has placed in the top 5% for net asset growth and is a proud recipient of the Chairman’s Club Award. Robert holds a bachelor’s degree in business management from Adelphi University, is a Certified Wealth Strategist (CWS®), a Chartered Retirement Planning Counselor (CRPC ®), and is currently enrolled in the Certified Financial Planner (CFP®) program at Kaplan Financial Institution. He maintains Series 6, 7, 63, 65, and Insurance licenses. About the Company Peapack-Gladstone Financial Corporation is a New Jersey bank holding company with total assets of $7.2 billion and assets under management and/or administration of $12.3 billion as of June 30, 2025. Founded in 1921, Peapack Private Bank & Trust is a commercial bank that offers a client-centric approach to banking, providing high-quality products along with customized and innovative wealth management, investment banking, commercial and personal banking solutions. The Bank’s wealth management division offers comprehensive financial, tax, fiduciary and investment advice and solutions to individuals, families, privately held businesses, family offices, and not-for-profit organizations, which help them establish, maintain, and expand their legacy. Peapack Private Bank & Trust offers an unparalleled commitment to client service. Visit www.peapackprivate.com for more information. Contact: Denise Pace-Sanders, Peapack Private Bank & Trust, SVP Managing Principal, Brand and Marketing Director, 500 Hills Drive, Suite 300, Bedminster, NJ 07921, dpace@peapackprivate.com, (908) 470-3322 View the original release on www.newmediawire.com News Source: Peapack-Gladstone Financial Corporation
25.09.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. |
| Language: | English |
| Company: | Peapack-Gladstone Financial Corporation |
| United States | |
| ISIN: | US7046991078 |
| EQS News ID: | 2204026 |
| End of News | EQS News Service |
|
|
2204026 25.09.2025 CET/CEST
Nachrichten zu Peapack Gladstone Financial Corp
|
06.11.25 |
EQS-News: Peapack Private Investment Banking Advises ACA Computers on Strategic Sale to Network Coverage (EQS Group) | |
|
03.10.25 |
EQS-News: Peapack Private Hires Alex Lurye to Join Its New York Commercial Banking Team (EQS Group) | |
|
25.09.25 |
EQS-News: Robert Melle Joins the Wealth Management Team at Peapack Private (EQS Group) | |
|
24.09.25 |
EQS-News: Peapack Private Hires Rebecca Wuest Creavin to Join Its Wealth Management Division (EQS Group) | |
|
12.09.25 |
EQS-News: Peapack Private Bank & Trust Expands Equipment Finance and Leasing Capabilities (EQS Group) | |
|
18.08.25 |
EQS-News: Greg Allison, CFP(R), Joins the Wealth Management Division at Peapack Private (EQS Group) | |
|
23.06.25 |
EQS-News: Paul F. Diamond, CFA, CFP Joins the Wealth Division of Peapack Private (EQS Group) | |
|
20.06.25 |
EQS-News: Blerina Limaj Joins Peapack Private's NY Commercial Banking Team (EQS Group) |
Analysen zu Peapack Gladstone Financial Corp
Mittwoch um 18 Uhr live: Die Illusion der Erinnerung - Wie du Denkfehler im Trading vermeidest
Erfahrung ist wertvoll - doch Erinnerungen sind trügerisch. Sie verzerren, ergänzen oder lassen Details weg, bis ein falsches Bild entsteht. Dieses Webinar zeigt, warum das Gehirn keine objektive Aufzeichnung liefert und wie diese Verzerrungen Trading-Entscheidungen unbewusst beeinflussen.
Schnell noch Plätze sichern!Abnehmspritzen – Ist der Hype vorbei? – mit Tim Schäfer
Ist der Hype um Abnehmspritzen wie bei Novo Nordisk und Eli Lilly vorbei – oder stehen wir erst am Anfang einer langfristigen Revolution im Gesundheitswesen? 💉📉
Im heutigen Gespräch mit Tim Schäfer @TimSchaeferMedia sprechen wir über die spannendsten Pharmawerte 2025. Neben den Abnehmspritzen blicken wir auch auf klassische Pharma-Giganten wie Pfizer, Johnson & Johnson, Roche, Novartis, AstraZeneca und GSK. Tim analysiert Übertreibungen, Rücksetzer und langfristige Chancen für Buy-and-Hold-Strategien – mit Fokus auf Dividende, KGV und Krisenresistenz.
💬 Was ist vom Abnehmtrend langfristig zu halten?
💬 Welche Pharma-Aktien sind aktuell unterbewertet?
💬 Was spricht für konservative Dividendenwerte im Gesundheitssektor?
👉🏽 https://bxplus.ch/wall-street-live-mit-tim-schaefer/
Inside Trading & Investment
Mini-Futures auf SMI
Inside Fonds
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
Warten auf anstehende Datenflut: Dow stark -- SMI letztlich fester -- DAX schliesslich freundlich -- Märkte in Fernost enden uneinheitlichSowohl der heimische als auch der deutsche Aktienmarkt präsentierten sich am Dienstag fester. Der US-Aktienmarkt bewegt sich am Dienstag in unterschiedliche Richtungen. Die wichtigsten asiatischen Börsen zeigten sich am Dienstag uneins.


